Most suicides in Minnesota occur in June, research shows
The National Alliance on Mental Illness (NAMI) Minnesota shared statistical data showing most suicides occur in June.
"It is really nerve-wracking," said David Goehl-Manolis, a suicide prevention coordinator for NAMI Minnesota, who remembers seeing a family member in distress. "At the time, I thought I knew about mental illness, and my worry for my family member paralyzed me."
A former school educator, he now aims to teach the public.
"Some people think that the holiday season has the most number of suicides, and the summer, there's fewer. Statistics show it's the opposite," Goehl-Manolis said.
He's referring to a 2023 University of Pennsylvania study.
"From a suicide prevention perspective, I don't think 'why' is really important," Goehl-Manolis said when asked why he thinks that is. He also emphasized that there's no "safe" time of year when it comes to suicide.
In a release last month, the Minnesota Department of Health says the suicide rate in Minnesota stayed about the same in 2024 when compared to 2023, according to preliminary data.
"That has not happened in almost two decades. It seems to be plateauing," said Goehl-Manolis.
The data also shows those under 25 in Minnesota are seeing lower suicide rates.
"Talk with people. It's okay to talk with the person who is struggling," Goehl-Manolis said. "People can recover. There's always a light."
If you or someone you know is in emotional distress, get help from the Suicide and Crisis Lifeline by calling or texting 988. Trained crisis counselors are available 24 hours a day to talk about anything.
In addition, help is available from the National Alliance on Mental Illness, or NAMI. Call the NAMI Helpline at 800-950-6264 or text "HelpLine" to 62640. There are more than 600 local NAMI organizations and affiliates across the country, many of which offer free support and education programs.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
an hour ago
- New York Times
Many Older People Embrace Vaccines. Research Is Proving Them Right.
Kim Beckham, an insurance agent in Victoria, Texas, had seen friends suffer so badly from shingles that she wanted to receive the first approved shingles vaccine as soon as it became available, even if she had to pay for it out of pocket. Her doctor and several pharmacies turned her down because she was below the recommended age at the time, which was 60. So in 2016, she celebrated her 60th birthday at her local CVS. 'I was there when they opened,' Ms. Beckham recalled. After her Zostavax shot, she said, 'I felt really relieved.' She has since received the newer, more effective shingles vaccine, as well as the pneumonia shot, the R.S.V. vaccine, annual flu shots and all recommended Covid vaccinations. Some older people are really eager to be vaccinated. Robin Wolaner, 71, a retired publisher in Sausalito, Calif., has been known to badger friends who delay getting recommended shots, sending them relevant medical studies. 'I'm sort of hectoring,' she acknowledged. Deana Hendrickson, 66, who provides daily care for three young grandsons in Los Angeles, sought an additional M.M.R. shot, though she was vaccinated as a child, in case her immunity to measles was waning. For older adults who express more confidence in vaccine safety than younger groups, the past few months have brought some welcome research. Studies have found important benefits from a newer vaccine and enhanced versions of older ones, and one vaccine may confer a major bonus that nobody had foreseen. Want all of The Times? Subscribe.
Yahoo
an hour ago
- Yahoo
Letters to Sports: Bill Plaschke is taking the fight to Parkinson's disease
Bill Plaschke, thank you for your very informative column about Parkinson's disease and your boxing exercise program. I was diagnosed with Parkinson's about five years ago and joined Rock Steady boxing in Burbank six months ago. We do Tai Chi, dancing, speech, the gym machines and boxing. We also work on stretching and floor exercises. My family has noticed a difference in my gait and my endurance. I hope that everyone with Parkinson's will take heed and find an exercise program specific to their needs. I never had a right jab before, but I have a good one now. Sandy Kaufman North Hollywood I'm often in the mood to punch him after reading one of Plaschke's columns, but after reading Sunday's column I wanted nothing more than to give him a hug. It reminds me that everyone is fighting a battle none of us can see. Be kind. Advertisement Bill Hokans Santa Ana Years of using Bill Plaschke's notoriously incorrect Super Bowl predictions for betting guidance has led me to believe that Bill owes me, as well as his many devoted readers, a significant debt. His brave and inspiring column revealing his ongoing battle with Parkinson's disease repays that debt, and then some. Rob Fleishman Placentia Don't mind admitting I was in tears reading about Bill Plaschke's advancing Parkinson's and the therapy that might slow the "motion-melting nightmare" down. A 78-year-old former rugby player with arthritis and a bum knee, I'm fortunate in not having to face the dreaded Parky (yet?). If it happens, I know where to go. Advertisement Rock on, Bill, and your truly inspiring gym mates. Kudos, also, to staff photographer Robert Gauthier … every picture, indeed, tells a story. John D.B. Grimshaw Lake Forest I too am living with Parkinson's disease. Plaschke's column helped to remind me that I am not alone and this dreaded disease indeed takes no prisoners no matter who you are. I wanted to thank Bill for his column bringing awareness, insight and hope to those of us diagnosed with Parkinson's. Bill's humanitarian columns with a tie-in to the world of sports showcase his best writing. Bill, your observations as a Parkinson's suffer truly hit the mark and deeply resonated with me. I wish you, and all of us afflicted with this condition, the willingness and determination to move forward and to use the power of sport and exercise to combat this devastating disease. Mike Feix Chino Hills Champion Bill Plaschke goes toe to toe against challenger 'Parky!' Plaschke delivers a vicious uppercut to his opponent. 'Down goes Parky, Down goes Parky!' Advertisement Rob Parra Rowland Heights Eye of the storm "Calm' is exactly right and what I admire most about Dodgers manager Dave Roberts. Not unlike his most illustrious predecessor, Walter Alston. Bob Wieting Simi Valley Back to the future Is the grass really greener if you can't see it? What poetic justice it would be if the Knicks had to end up rehiring Tom Thibodeau and have to give him more money and more authority? If it ain't broke don't fix it. Russell Morgan Carson Unheralded heroes It's been a minute since we've seen an outfielder with an arm like Andy Pages. I've taken to calling him the "Cuban Cannon." As for Hyeseong Kim, he has been a sparkplug for the offense. I am trying hard to figure out why he doesn't command more playing time. Advertisement John Tsutsui Hurricane, Utah Arms game Kiké "The Closer" Hernández. Who needs Shohei Ohtani, Blake Snell or Tyler Glasnow? Brent Montgomery Long Beach The Los Angeles Times welcomes expressions of all views. Letters should be brief and become the property of The Times. They may be edited and republished in any format. Each must include a valid mailing address and telephone number. Pseudonyms will not be used. Email: sports@ Get the best, most interesting and strangest stories of the day from the L.A. sports scene and beyond from our newsletter The Sports Report. This story originally appeared in Los Angeles Times.
Washington Post
an hour ago
- Washington Post
Celebrated, then disparaged: mRNA's promise is tarnished under Trump
The four letters were the toast of the scientific world, the engine powering vaccines developed in record time that saved millions of lives and helped tame the covid-19 pandemic: mRNA. But despite President Donald Trump's boasting in his first term that mRNA vaccines were a 'modern-day miracle,' his appointees are now throwing doubt on the technology with largely unfounded claims about its safety, canceling funding for future discoveries and handing key posts to prominent mRNA critics. The administration's abrupt turn against one of the biggest biotech breakthroughs in modern times has triggered confusion and worry among scientists and drug companies researching the use of mRNA to stem future pandemics, as well as to treat cancer, cystic fibrosis and other diseases.
